bevacizumab,atezolizumab
roche
['atezo', ' bev ', 'hcc']
adjuvant atezo plus bev for hcc . postive study. but we need to wait for os . we may not get os . if we give atezo plus bev upfront then what on relapse ? #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists